CHARACTERIZATION OF CONTRACTILE ENDOTHELIN AND ANGIOTENSIN RECEPTORS IN HUMAN RESISTANCE ARTERIES - EVIDENCE FOR 2 ENDOTHELIN AND ONE ANGIOTENSIN RECEPTOR

被引:41
作者
TSCHUDI, MR
LUSCHER, TF
机构
[1] UNIV HOSP BERN,INSELSPITAL,DIV CARDIOL,CH-3010 BERN,SWITZERLAND
[2] UNIV BASEL HOSP,DEPT RES,CH-4031 BASEL,SWITZERLAND
关键词
D O I
10.1006/bbrc.1994.2514
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endothelin-1 (ET-1) and angiotensin II (AII) are potent vasoconstrictor hormones which regulate tissue perfusion and blood pressure. We pharmacologically characterized endothelin and angiotensin receptors mediating contractions of human mammary resistance arteries in myographs for isometric tension recording. ET-1 caused potent contractions. The concentration response curve was shifted to the right by ET(A) antagonist FR 139317, but a high sensitivity, low efficacy component remained. After incubation with ET(B) agonist sarafotoxin (S6c) this component of the concentration response curve resistant to FR 139317 disappeared. The ET(A)/ET(B)-receptor antagonist bosentan shifted the entire concentration response curve to the right. AI and AII caused marked contractions, The effects of AI were reduced by the ACE inhibitor benazeprilat, while those of AII were prevented by valsartan, an AT(1) antagonist. In summary, in human resistance arteries, contractions to ET-1 are mediated by ET(A)- and ET(B)-receptors while those to AII are exclusively mediated by AT(1)-receptors. 1994 Academic Inc. Press,
引用
收藏
页码:685 / 690
页数:6
相关论文
共 21 条
[1]   CLONING AND EXPRESSION OF A CDNA-ENCODING AN ENDOTHELIN RECEPTOR [J].
ARAI, H ;
HORI, S ;
ARAMORI, I ;
OHKUBO, H ;
NAKANISHI, S .
NATURE, 1990, 348 (6303) :730-732
[2]   IN-VITRO CHARACTERIZATION OF RO 46-2005, A NOVEL SYNTHETIC NONPEPTIDE ENDOTHELIN ANTAGONIST OF ET(A) AND ET(B) RECEPTORS [J].
BREU, V ;
LOFFLER, BM ;
CLOZEL, M .
FEBS LETTERS, 1993, 334 (02) :210-214
[3]   THE ENDOTHELIN ET(B) RECEPTOR MEDIATES BOTH VASODILATION AND VASOCONSTRICTION INVIVO [J].
CLOZEL, M ;
GRAY, GA ;
BREU, V ;
LOFFLER, BM ;
OSTERWALDER, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 186 (02) :867-873
[4]   PHARMACOLOGICAL PROFILE OF VALSARTAN - A POTENT, ORALLY-ACTIVE, NONPEPTIDE ANTAGONIST OF THE ANGIOTENSIN-II AT1-RECEPTOR SUBTYPE [J].
CRISCIONE, L ;
DEGASPARO, M ;
BUHLMAYER, P ;
WHITEBREAD, S ;
RAMJOUE, HPR ;
WOOD, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (02) :761-771
[5]   ENDOTHELIN IN HYPERTENSIVE RESISTANCE ARTERIES - INTRALUMINAL AND EXTRALUMINAL DYSFUNCTION [J].
DOHI, Y ;
LUSCHER, TF .
HYPERTENSION, 1991, 18 (04) :543-549
[6]   SIGNIFICANCE OF THE VASCULAR RENIN-ANGIOTENSIN PATHWAY [J].
DZAU, VJ .
HYPERTENSION, 1986, 8 (07) :553-559
[7]   HETEROGENEITY OF ENDOTHELIN-SARAFOTOXIN RECEPTORS MEDIATING CONTRACTION OF PIG CORONARY-ARTERY [J].
HARRISON, VJ ;
RANDRIANTSOA, A ;
SCHOEFFTER, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (03) :511-513
[8]  
KURODA K, 1990, ARZNEIMITTEL-FORSCH, V40-2, P968
[9]   DO WE NEED ENDOTHELIN ANTAGONISTS [J].
LUSCHER, TF .
CARDIOVASCULAR RESEARCH, 1993, 27 (12) :2089-2093
[10]   ENDOTHELIUM-DERIVED CONTRACTING FACTORS [J].
LUSCHER, TF ;
BOULANGER, CM ;
DOHI, Y ;
YANG, ZH .
HYPERTENSION, 1992, 19 (02) :117-130